26.27
Clearpoint Neuro Inc stock is traded at $26.27, with a volume of 901.59K.
It is up +0.61% in the last 24 hours and up +150.43% over the past month.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.
See More
Previous Close:
$26.11
Open:
$26.86
24h Volume:
901.59K
Relative Volume:
1.19
Market Cap:
$746.79M
Revenue:
$30.43M
Net Income/Loss:
$-18.15M
P/E Ratio:
-38.07
EPS:
-0.69
Net Cash Flow:
$-9.08M
1W Performance:
-1.20%
1M Performance:
+150.43%
6M Performance:
+129.03%
1Y Performance:
+126.27%
Clearpoint Neuro Inc Stock (CLPT) Company Profile
Name
Clearpoint Neuro Inc
Sector
Industry
Phone
(949) 900-6833
Address
120 S. SIERRA AVENUE, SOLANA BEACH, CA
Compare CLPT with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CLPT
Clearpoint Neuro Inc
|
26.27 | 742.24M | 30.43M | -18.15M | -9.08M | -0.69 |
![]()
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
![]()
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
![]()
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
![]()
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
![]()
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Clearpoint Neuro Inc Stock (CLPT) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-25-24 | Resumed | B. Riley Securities | Buy |
Oct-24-23 | Initiated | Stifel | Buy |
Feb-16-23 | Resumed | B. Riley Securities | Buy |
Apr-05-22 | Resumed | B. Riley Securities | Buy |
Mar-18-21 | Initiated | Lake Street | Buy |
Jul-17-20 | Initiated | B. Riley FBR | Buy |
View All
Clearpoint Neuro Inc Stock (CLPT) Latest News
Will earnings trigger a reversal in ClearPoint Neuro Inc.2025 Price Momentum & Verified Swing Trading Watchlists - newser.com
What momentum indicators show for ClearPoint Neuro Inc. stockMarket Trend Report & Verified Stock Trade Ideas - newser.com
Tools to assess ClearPoint Neuro Inc.’s risk profileDip Buying & Short-Term Trading Alerts - newser.com
Can ClearPoint Neuro Inc. stock hit record highs againPortfolio Return Report & Entry and Exit Point Strategies - newser.com
Using economic indicators to assess ClearPoint Neuro Inc. potentialLong Setup & Stepwise Entry and Exit Trade Signals - newser.com
Will ClearPoint Neuro Inc. stock beat EPS estimatesJuly 2025 Technicals & Fast Momentum Stock Entry Tips - newser.com
ClearPoint Neuro (NASDAQ:CLPT) Sets New 1-Year HighTime to Buy? - MarketBeat
What’s next for ClearPoint Neuro Inc. stock priceEarnings Performance Report & Precise Swing Trade Entry Alerts - newser.com
Combining machine learning predictions for ClearPoint Neuro Inc.July 2025 PostEarnings & Reliable Price Breakout Alerts - newser.com
ClearPoint Neuro's (CLPT) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Clearpoint Neuro, Inc. Hits New 52-Week High of $29.85 - Markets Mojo
ClearPoint Neuro (NASDAQ:CLPT) Trading Up 7.4%Should You Buy? - MarketBeat
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be presented at the CNS Annual Meeting in Los Angeles - MarketScreener
ClearPoint Neuro reports positive results from brain tumor laser therapy study - Investing.com Nigeria
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles - Stock Titan
ClearPoint Neuro expands regulatory approvals to 34 countries By Investing.com - Investing.com Nigeria
ClearPoint Neuro expands regulatory approvals to 34 countries - Investing.com
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide - ACCESS Newswire
34 Countries: ClearPoint Neuro Expands Regulatory Clearances with Canada, Hong Kong and Taiwan additions - Stock Titan
Clearpoint Neuro Reaches New 52-Week High of $28.80, Up 377% - Markets Mojo
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies - The Globe and Mail
Will ClearPoint Neuro Inc. stock benefit from automationJuly 2025 Macro Moves & Reliable Price Breakout Signals - newser.com
Using RSI to spot recovery in ClearPoint Neuro Inc.Trade Volume Report & Real-Time Stock Price Movement Reports - newser.com
Using data models to predict ClearPoint Neuro Inc. stock movementSell Signal & Daily Growth Stock Investment Tips - newser.com
Will ClearPoint Neuro Inc. stock outperform value stocksQuarterly Market Review & Real-Time Stock Price Movement Reports - newser.com
Can ClearPoint Neuro’s (CLPT) New Robotic Platform Redefine Its Clinical Expansion Trajectory? - Sahm
ClearPoint Neuro (NASDAQ:CLPT) Reaches New 12-Month High – Here’s What Happened - Defense World
ClearPoint Neuro (CLPT): Gauging Valuation After Robotic Innovation, Insider Buying, and Huntington’s Therapy Progress - Yahoo Finance
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target - MSN
ClearPoint Neuro (CLPT): Evaluating Valuation After Dr. Paul Larson Announced as Incoming Chief Medical Officer - Sahm
ClearPoint Neuro adds to gains, up 125% since Sept 23 - TradingView
ClearPoint Neuro (NASDAQ:CLPT) Hits New 52-Week HighHere's What Happened - MarketBeat
ClearPoint Neuro: AMT-130 Highlights A Bright Future (NASDAQ:CLPT) - Seeking Alpha
ClearPoint Neuro (NASDAQ:CLPT) Trading Up 5.9%Still a Buy? - MarketBeat
ClearPoint Neuro developing robotic navigation system for brain surgeries - Investing.com
ClearPoint Neuro developing robotic navigation system for brain surgeries By Investing.com - Investing.com Australia
ClearPoint Neuro : Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System - MarketScreener
ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System - ACCESS Newswire
Revolutionary Robot-Guided Brain Navigation System: ClearPoint Neuro's New Platform for Gene Therapy Delivery - Stock Titan
Clearpoint Neuro, Inc. Hits New 52-Week High of $22.38 - Markets Mojo
Is ClearPoint Neuro Inc a good long term investmentSector ETF Performance & Access Powerful Market Insights - earlytimes.in
Clearpoint Neuro Inc Stock (CLPT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Clearpoint Neuro Inc Stock (CLPT) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Richards Timothy T. | Director |
Jun 10 '25 |
Sale |
13.28 |
10,000 |
132,800 |
77,381 |
BURNETT JOSEPH | CEO and President |
Jun 09 '25 |
Sale |
13.29 |
21,247 |
282,373 |
243,522 |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):